HHS Reaches 10th Risk-Analysis Enforcement Action as HIPAA Audits Intensify

OCR's risk-analysis enforcement reaches double digits

HHS's Office for Civil Rights has completed its 10th enforcement action under its risk-analysis initiative, with nine 2026 settlements totaling approximately $2.98 million in penalties. Every case involved a missing or inadequate risk assessment. The pattern makes documented, current risk analysis the most predictable enforcement target for covered entities and business associates.

The latest public settlement during the period was October 8, 2026, with Dr. Linda L. Shen, doing business as Shen Smiles, P.C., under the HIPAA Privacy Rule. The enforcement trend spans small practices and larger organizations, indicating that OCR is not limiting scrutiny to high-profile breaches.

For healthcare technology buyers, this creates a clear budget priority: recurring risk assessments with auditable records. A point-in-time assessment is no longer sufficient. Procurement teams should require timestamped evidence, assigned remediation owners, review histories, and exports designed for OCR inquiries. The financial risk is measurable—2026 enforcement alone has reached nearly $3 million across nine actions.

HHS releases free Security Risk Assessment Tool 3.7

HHS's Office for Civil Rights and the Assistant Secretary for Technology Policy released Version 3.7 of the HIPAA Security Risk Assessment Tool, along with an updated user guide. The tool is free and intended to help covered entities and business associates identify vulnerabilities and document Security Rule compliance.

The free federal tool competes indirectly with paid HIPAA assessment and compliance-management products. It may reduce the need for small organizations to purchase a basic questionnaire product, but it does not replace enterprise capabilities such as continuous asset discovery, automated control testing, security telemetry, vendor-risk workflows, ticketing integrations, or executive reporting.

Enterprise buyers should treat Version 3.7 as a baseline control and documentation reference, not a full compliance platform. Procurement teams can use it to test whether commercial vendors—including Kaseya/Compliance Manager, Accountable, HIPAA One, MedTrainer, Compliancy Group, Microsoft Purview, and Vanta—add measurable value beyond a standardized assessment. The differentiator is integration: identity systems, endpoint management, vulnerability tracking, backup verification, SIEM platforms, and ticketing tools.

OIG report calls for stronger HIPAA audit program

The HHS Office of Inspector General issued a report on October 2, 2026, titled "The Office for Civil Rights Should Enhance Its HIPAA Audit Program to Enforce HIPAA Requirements and Improve the Protection of Electronic Protected Health Information." The report signals greater audit scrutiny, even without a quantified implementation timetable or additional audit volume.

Stronger auditing shifts buying decisions toward platforms that continuously preserve evidence of control operation. This benefits established GRC suites and healthcare-focused compliance vendors over manual spreadsheets or annual consulting engagements. It also raises the importance of third-party risk and business-associate oversight, where healthcare organizations often lack centralized evidence.

Buyers should expect compliance budgets to move from preparation-only activities toward continuous audit readiness. RFPs should ask vendors to demonstrate how they retain evidence for the HIPAA documentation period, map controls to Security Rule requirements, track exceptions, and produce an examiner-ready audit trail.

Proposed Security Rule update remains in long-term queue

The proposed HIPAA Security Rule update has not been finalized. The proposal was published January 6, 2025, comments closed March 7, 2025, and the regulatory agenda moved final action to "Long-Term Actions," with a projected completion date of July 2027.

The proposal includes measures such as encryption, multifactor authentication, asset inventories, tested backups, and regular audits, but these are not currently final federal mandates. The delay creates a two-speed market. Some providers will defer spending until a final rule appears, while larger health systems and insurers are likely to implement the proposed controls proactively because OCR's existing risk-analysis enforcement already supports many of the same practices.

Enterprise buyers should avoid purchasing solely for a promised future rule certification. Instead, prioritize controls that address current risk and are likely to remain useful under any final rule: MFA, encryption, asset inventories, tested recovery, vulnerability remediation, documented risk analysis, and continuous evidence collection.

What to watch

The near-term compliance signal is enforcement, not a finalized new rule. The combination of approximately $2.98 million in nine 2026 enforcement actions, a 10th risk-analysis action, the free SRA Tool Version 3.7, and an OIG call for stronger audits makes documented, continuously updated risk analysis the clearest immediate budget priority.

Healthcare organizations should prepare for a shift from annual assessments to continuous audit readiness. Vendors that integrate with existing security and IT infrastructure will have a competitive advantage over standalone questionnaire tools. The regulatory delay on the Security Rule update does not reduce enforcement risk—it increases the importance of evidence that demonstrates ongoing attention to risk management, not a one-time compliance checkbox.